Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
385,837,333
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
14,924,359
-
Shares change
-
+399,641
-
Total reported value, excl. options
-
$76,044,039
-
Value change
-
+$1,681,413
-
Number of buys
-
11
-
Number of sells
-
-26
-
Price
-
$5.1
Significant Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q4 2017
54 filings reported holding TRIB - Trinity Biotech plc - Class 'A' Ordinary Shares as of Q4 2017.
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14,924,359 shares
of 385,837,333 outstanding shares and own 3.87% of the company stock.
Largest 10 shareholders include Paradice Investment Management LLC (1,639,296 shares), JANUS HENDERSON GROUP PLC (1,414,291 shares), HEARTLAND ADVISORS INC (1,346,150 shares), Russell Investments Group, Ltd. (1,201,488 shares), Lapides Asset Management, LLC (1,173,400 shares), Boston Partners (1,074,220 shares), FIRST WILSHIRE SECURITIES MANAGEMENT INC (1,026,624 shares), Senvest Management, LLC (1,003,988 shares), 22NW, LP (873,594 shares), and STONEHILL CAPITAL MANAGEMENT LLC (738,829 shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.